It is a pharma private limited company based in Haridwar, Uttarakhand, India, established in 2003.
2003 | Haridwar, Uttarakhand, India | ActiveCorum Lifesciences Private Limited, a active private limited company, was established on 30 December 2003 in Haridwar, Uttarakhand, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U50000UR2003PTC028174. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹6.00 Cr.
Formerly known as Northern Beverages (India) Private Limited. It upholds a active non-compliant status. Its leadership includes Saarah Khurram (Director), Khurram Malik (Director). Past directors included Rajat Aswal, Abdul Rehman, Khurram Malik. It holds ₹7.15 Cr open charges and ₹4.25 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 51-56,Sector -5, Iie,Sidcul, Haridwar, Uttarakhand, 249402.
U50000UR2003PTC028174
028174
30 December 2003
₹7.50 Cr
₹6.00 Cr
Roc Uttarakhand
Unlisted
Active
Explore comprehensive insights into Corum Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saarah Khurram | Director | 02 May 2014 | Current |
| Khurram Malik | Director | 02 Aug 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Sep 2014 | Past |
| Pramod Abcsdd | Director | 26 Apr 2014 | Past |
| Pramod Abcsdd | Director | 12 May 2014 | Past |
| Pramod Abcsdd | Director | 26 Apr 2014 | Past |
| Pramod Abcsdd | Director | 26 Apr 2014 | Past |
| Pramod Abcsdd | Director | 26 Apr 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Corum Lifesciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.71% decrease. The company also saw a slight improvement in profitability, with a 9.69% increase in profit. The company's net worth moved up by a moderate rise of 3.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Corum Lifesciences had a promoter holding of 40.00% and a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹71,500,000.00
₹42,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jan 2015 | Dena Bank | ₹7.15 Cr | Open |
| 13 May 2014 | Punjab National Bank | ₹3.50 Cr | Satisfied |
| 28 Sep 2007 | Canara Bank | ₹7.50 M | Satisfied |
Explore comprehensive loan charge details -
Corum Lifesciences has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Corum Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corum Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Corum Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Corum Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand. was recorded as a recent event.
Progress on A charge with Dena Bank of Rs. 7.15 Cr registered on 13 Jan 2015 with Charge ID 10548040 was modified on 30 Jun 2016. was documented.
The activity A charge registered on 13 May 2014 via Charge ID 10500456 with Punjab National Bank was fully satisfied on 27 Jan 2015. was completed.
Progress on A charge with Dena Bank amounted to Rs. 7.15 Cr with Charge ID 10548040 was registered on 13 Jan 2015. was documented.
The activity Khurram Malik was appointed as a Director was appointed as a Director on 02 Aug 2014 & has been associated with this company since 11 years 4 months . was completed.
The CIN of Corum Lifesciences Private Limited is U50000UR2003PTC028174.
Corum Lifesciences Private Limited is headquartered at 51-56,Sector -5, Iie,Sidcul, Haridwar, Uttarakhand, 249402.
Corum Lifesciences Private Limited was incorporated on 30 December 2003.
The current directors of Corum Lifesciences Private Limited are
The primary industry of Corum Lifesciences Private Limited is Manufacturing.
Corum Lifesciences Private Limited is unlisted.
The authorized capital of Corum Lifesciences Private Limited is ₹7.50 Cr, and the paid-up capital is ₹6.00 Cr.
The compliance status of Corum Lifesciences Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX